AJMC Staff

Health care institutions with large numbers of Medicare and Medicaid patients may be constrained from offering cancer therapies made available under the accelerated approval pathway.

The companies announced the deal in a statement February 5, 2025, noting that the first patient had enrolled in a prospective clinical study using the test to monitor cancer recurrence across multiple solid tumor types.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

A statement about the acquisition promises that Navigating Cancer will operate independently with no differences in service regardless of a practice's status with a management service organization.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Roughly 7% of US women of reproductive age have attempted self-induced abortions after the overturning of Roe v Wade in 2022; the FDA announced that the cost to file a drug using clinical data will increase to about $4.3 million in 2025; the suicide rate among US children aged between 8 to 12 years has steadily risen during the past 15 years.

Smokers with diabetes on Ozempic are less likely to receive smoking cessation interventions; initiative incentivizes hospitals to eliminate medical debt for low- and middle-income patients; high costs prevent mental health treatment.

Efforts aim to protect health sector from rising threats; chronic anxiety nearly triples dementia risk; patients report overdoses up to 20 times the prescribed dosage of compounded semaglutide.

The ending of the 2023 film “Barbie,” where she sees a gynecologist, has increased online search interest in gynecology; yesterday marked 34 years of the Americans With Disabilities Act (ADA); Texas Attorney General Ken Paxton is suing the Biden administration over Title X, a federal contraception program that provides teens birth control without parental consent.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

A federal appeals court ruled yesterday that a group of Republican-led states do not have legal standing to impose restrictions on the abortion pill mifepristone; the US infant mortality rate increased by 3% in 2022; a twice-yearly injection could prevent 100% of HIV infections.

Lawmakers cross-examined pharmacy benefit manager (PBM) representatives during a Congressional hearing; the proportion of hospital inpatients covered by private Medicare Advantage (MA) plans is rapidly increasing; public health officials are concerned after poliovirus was found in sewage samples from Gaza.

Efforts to regulate social media for youth face resistance; MK-1654 meets key goals in mid-to-late stage trial; active drug shortages remain above 300 for sixth consecutive quarter.

New rules aim to curb insurance brokers and protect consumers; data highlights surge in post-pandemic hospital-onset infections; President Biden’s decision to step down highlights Harris’ stance on health care reform and equity.

Rising COVID-19 cases are attributed to travel, heatwaves, and new variants; an analysis highlights challenges in states not expanding Medicaid; the FDA notes health risks despite marketing authorization for popular e-cigarettes.